References
- 1. Schaller MA, Wicke F, Foerch C, etc. Central Nervous System Tuberculosis. Clin Neuroradiol. 2019; 29: 3–18.10.1007/s00062-018-0726-930225516
- 2. Monteiro R, Carneiro JC, Costa C, etc. Cerebral tuberculomas - A clinical challenge, Respiratory Medicine Case Reports. 2013; 9: 34-7.10.1016/j.rmcr.2013.04.003
- 3. Rock RB, Olin M, Baker CA, etc. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clinical Microbiology Reviews. 2008; 21(2): 243-61.10.1128/CMR.00042-07229257118400795
- 4. Taheri S, Karimi M, Haghighatkhah H, etc. Central Nervous System Tuberculosis: An Imaging-Focused Review of a Reemerging Disease, Radiology Research and Practice. 2015.10.1155/2015/202806430638325653877
- 5. Cherian A, Thomas SV, Central nervous system tuberculosis, African Health Sciences 2011; 11(1): 116–27.
- 6. Hopewell PC, Kaufmann SHE, van Helden P. Clinical features of tuberculosis, Handbook of tuberculosis: clinics, diagnostics, therapy and epidemiology. 2008; 89–113.10.1002/9783527611614.ch37
- 7. Kumar RC, Pandey K, Bose N, etc. Tuberculous brain abscess: clinical presentation, pathophysiology and treatment (in children), Childs Nerv. Syst. 2002; 18:118–23.10.1007/s00381-002-0575-211981617
- 8. Thwaites G, Fisher M, Hemingway C, etc. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children, Journal of Infection. 2009; 59: 167-87.10.1016/j.jinf.2009.06.011
- 9. DeLance AR, Safaee M, Oh MC, Clark AJ, etc. Tuberculoma of the central nervous system, Journal of Clinical Neuroscience. 2013; 20(10): 1333–41.10.1016/j.jocn.2013.01.008
- 10. Trivedi R, Saksena S, Gupta RK. Magnetic resonance imaging in central nervous system tuberculosis, Indian J Radiol Imaging. 2009; 19: 256–65.10.4103/0971-3026.57205
- 11. Wasay M, Moolani MK, Zaheer J, etc. Prognostic Indicators in pacients with intracranial tuberculoma- a review of 102 cases. J Pak Med Assoc. 2004; 54(2): 83-7.
- 12. Lanzafame M, Vento S, Tuberculosis-immune reconstitution inflammatory syndrome, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2016; 3: 6–9.10.1016/j.jctube.2016.03.002685022831723680
- 13. Geri G, Passeron A, Heym B, etc. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection. 2013; 41:537–43.10.1007/s15010-012-0376-923203899
- 14. Jung JW, Shin JW, Kim JY, etc. Risk factors for development of paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pleural tuberculosis, Tohoku J Exp Med. 2011; 223:199–204.10.1620/tjem.223.199
- 15. Lewinsohn DM, Leonard MK, LoBue PA, etc. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children, Clinical Infectious Diseases. 2017; 64(2):e1–e33.10.1093/cid/ciw69427932390
- 16. Poonnoose SI, Rajshekhar V. Rate of resolution of histologically verified intracranial tuberculomas. Neurosurgery. 2003; 53: 873-9.10.1227/01.NEU.0000083553.25421.6F
- 17. Jain SK, Kwon P, Moss WJ. Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: case report and review. Clinical Pediatrics. 2005; 44: 443-50.10.1177/00099228050440051015965552
- 18. Wasay M. Central nervous system tuberculosis and paradoxical response. South Med J. 2006; 99: 331–2.10.1097/01.smj.0000209231.88651.0716634237